On January 12, 2026, USANA Health Sciences, Inc. announced preliminary net sales for the fiscal year ending January 3, 2026, along with guidance for the upcoming fiscal year ending January 2, 2027. This event is considered significant for investors as it provides insights into the company's financial performance and expectations going forward.